| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥304.1B | ¥290.7B | +4.6% |
| Operating Income | ¥20.7B | ¥30.7B | -32.5% |
| Ordinary Income | ¥19.9B | ¥31.0B | -35.9% |
| Net Income | ¥13.6B | ¥20.9B | -35.0% |
| ROE | 5.2% | 8.4% | - |
FY2025 Q3 results show revenue growth accompanied by significant profit decline. Revenue reached 304.1B yen (YoY +4.6%), while Operating Income fell to 20.7B yen (YoY -32.5%), Ordinary Income declined to 19.9B yen (YoY -35.9%), and Net Income decreased to 13.6B yen (YoY -35.0%). The quarter demonstrates a concerning pattern of margin compression despite top-line expansion, with operating margin declining to 6.8% from approximately 10.6% in the prior year period. The profitability deterioration was driven by gross margin pressure at 19.7% and increasing interest expenses of 2.4B yen compared to 1.5B yen in the prior year. Total assets declined slightly to 651.8B yen from 658.6B yen, while equity increased to 259.8B yen from 248.3B yen, maintaining an equity ratio of 39.9%.
Revenue grew 13.4B yen or 4.6% YoY to 304.1B yen, demonstrating continued demand strength. However, this top-line expansion was insufficient to offset margin compression and cost increases. The gross profit margin declined to approximately 19.7%, indicating either unfavorable product mix shifts, pricing pressure, or rising input costs. Operating expenses increased at a faster pace than revenue, with selling, general and administrative expenses rising to 39.1B yen from 37.2B yen YoY, representing an SG&A ratio of 12.9%. This resulted in operating income declining 10.0B yen or 32.5% to 20.7B yen.
The profit deterioration accelerated at the ordinary income level, declining 11.1B yen or 35.9% to 19.9B yen. Non-operating expenses exceeded non-operating income by 0.8B yen, primarily driven by interest expenses of 2.4B yen, up 0.9B yen or 61% YoY. This substantial increase in interest burden reflects both higher short-term borrowing levels (63.0B yen, up 37% YoY) and the rising interest rate environment. Foreign exchange gains of 0.5B yen provided partial offset but were insufficient to neutralize the financing cost increases.
Net income declined 7.3B yen or 35.0% to 13.6B yen, with the tax burden coefficient at 68.9%. The profit decline was driven by operational margin compression rather than extraordinary items, as no material impairment losses or restructuring charges were recorded during the quarter. Working capital efficiency deteriorated significantly, with accounts receivable reaching 89.0B yen and inventory at 87.8B yen, representing substantial asset intensity that constrains cash generation and profitability.
This quarter represents a revenue up, profit down pattern, where top-line growth was more than offset by deteriorating unit economics, operating leverage loss, and increased financial expenses.
The company operates two primary segments with contrasting profitability profiles. Chemicals segment generated revenue of 118.8B yen with operating income of 20.4B yen, representing an operating margin of 17.2% and constituting the core business with the highest profitability. PhotosensitivityMaterials segment recorded revenue of 188.1B yen with operating income of 0.3B yen, representing an operating margin of just 0.2%. The material margin differential of 17.0 percentage points between segments highlights concentration of profitability in Chemicals. PhotosensitivityMaterials, despite generating 61% of combined segment revenue, contributes minimally to operating profit, indicating either competitive pressures, product maturity, or structural cost challenges in this segment. The segment profit reconciles to consolidated operating income of 20.7B yen as noted in segment footnotes.
[Profitability] ROE of 5.2% reflects modest return on shareholder capital, impacted by the 35.0% decline in net income. Net profit margin compressed to 4.5% from approximately 7.2% in the prior year, indicating significant profitability deterioration. Operating margin declined to 6.8% from approximately 10.6% YoY, a decrease of 3.8 percentage points. EBIT margin stood at 6.8%, constrained by gross margin pressure and operating expense growth. [Cash Quality] Cash and deposits totaled 30.0B yen, providing short-term debt coverage of 0.48x against short-term borrowings of 63.0B yen, indicating limited liquidity cushion. [Investment Efficiency] Asset turnover of 0.47x remains below optimal levels, with total assets of 651.8B yen supporting annualized revenue generation inefficiently. ROIC of 3.2% significantly underperforms, indicating capital allocation challenges. [Financial Health] Equity ratio of 39.9% represents moderate financial stability, declining from 37.7% in the prior year period. Current ratio of 116.1% and quick ratio of 74.4% signal constrained liquidity with limited immediate asset coverage. Debt-to-equity ratio of 0.82x reflects moderate leverage, with interest-bearing debt of 212.7B yen against equity of 259.8B yen.
Cash and deposits decreased 5.2B yen YoY to 30.0B yen, reflecting pressure on liquidity despite profitability. Working capital absorption intensified with accounts receivable increasing to 89.0B yen and inventory reaching 87.8B yen, together representing 176.8B yen or 27.1% of total assets, indicating significant cash tied up in operations. The increase in short-term borrowings by 17.0B yen to 63.0B yen compensated for working capital expansion and operational funding needs. Accounts payable stood at 51.3B yen, providing some supplier credit utilization but insufficient to offset the working capital buildup. The cash coverage of short-term liabilities at 0.48x represents a constrained position requiring monitoring. Total liabilities of 392.0B yen against current assets of 244.2B yen indicates reliance on asset turnover and refinancing capability to maintain liquidity. The substantial working capital intensity with receivables days of approximately 107 days and inventory days exceeding 130 days constrains cash conversion efficiency.
Ordinary income of 19.9B yen compared to operating income of 20.7B yen indicates net non-operating costs of 0.8B yen. This comprises primarily interest expenses of 2.4B yen partially offset by non-operating income including foreign exchange gains of 0.5B yen and equity method investment income. Non-operating expense represents 0.9% of revenue, concentrated in financial costs. The substantial increase in interest burden from 1.5B yen to 2.4B yen YoY (61% increase) reflects both volume and rate effects from expanded short-term borrowings. The minimal gap between ordinary income and operating income of 0.8B yen suggests limited reliance on non-operating items, with core profitability challenges residing in operating performance. However, the absence of operating cash flow disclosure prevents assessment of accruals quality and cash earnings realization. The deteriorating working capital metrics with elevated receivables and inventory levels suggest potential risk of revenue recognition outpacing cash collection, warranting attention to earnings quality sustainability.
Full-year guidance projects revenue of 415.0B yen, operating income of 28.0B yen, ordinary income of 26.0B yen, and net income of 20.0B yen. Q3 progress rates stand at revenue 73.3%, operating income 73.9%, ordinary income 76.5%, and net income 67.9% of full-year targets. These progress rates align reasonably with the 75% standard for Q3, though net income trails slightly at 68%. The company forecasts full-year revenue growth of 7.3% but operating income decline of 31.8%, ordinary income decline of 35.0%, and net income decline of 39.0%, consistent with year-to-date trends. The guidance implies modest Q4 performance with operating income of approximately 7.3B yen and net income of 6.4B yen required to meet targets. Given Q3 operating income of 20.7B yen and year-to-date run rates, achieving full-year guidance appears attainable but requires sustained execution. The structural margin pressure and elevated working capital intensity observed through Q3 present downside risks to profit guidance if operational improvements are not realized in Q4.
The company maintains a dividend policy with interim dividend of 20.00 yen per share and planned year-end dividend of 25.00 yen per share for a total annual dividend of 45.00 yen. Based on net income of 13.6B yen for Q3 and basic EPS of 171.04 yen, the payout ratio calculates to approximately 26.3% on a trailing basis or 27.0% against full-year earnings guidance. This conservative payout ratio provides dividend sustainability cushion despite the 35.0% earnings decline. No share buyback activity was disclosed during the quarter. The total return ratio equals the payout ratio at approximately 27%, indicating capital return focused exclusively on dividends. The dividend policy appears sustainable given the moderate payout ratio, though the absence of operating cash flow disclosure limits assessment of cash-backed dividend coverage. Maintaining the dividend despite significant earnings decline signals management commitment to shareholder returns, though future sustainability depends on operational recovery and cash generation improvement.
Liquidity stress represents the primary near-term risk, with cash-to-short-term debt coverage of only 0.48x and short-term borrowings of 63.0B yen increasing 37% YoY. The company faces refinancing risk if unable to roll over short-term debt or access alternative funding sources. Working capital deterioration poses significant cash flow risk, with accounts receivable of 89.0B yen and inventory of 87.8B yen representing excessive asset intensity. Days sales outstanding of approximately 107 days and inventory days exceeding 130 days indicate potential collection delays or inventory obsolescence risk, which could impair both profitability and liquidity. Margin compression risk persists with gross profit margin at 19.7% and operating margin declining to 6.8%, reflecting either competitive pricing pressure, unfavorable product mix, or unabsorbed costs. The PhotosensitivityMaterials segment operating margin of only 0.2% indicates structural profitability challenges requiring strategic intervention. Interest rate exposure has intensified with interest expenses increasing 61% YoY to 2.4B yen, and further rate increases would compound financial costs on the 212.7B yen interest-bearing debt balance.
[Industry Position] (Reference - Proprietary Analysis)
The company's profitability metrics lag manufacturing industry medians. ROE of 5.2% aligns with the industry median of 5.0% (2025-Q3, n=98), indicating peer-level equity returns despite the substantial YoY earnings decline. Operating margin of 6.8% falls below the industry median of 8.3% (IQR: 4.8%-12.6%), positioning the company in the lower half of sector profitability. Net profit margin of 4.5% significantly underperforms the industry median of 6.3% (IQR: 3.2%-9.0%), reflecting the company's margin compression challenges.
Financial health metrics show elevated leverage and constrained liquidity. The equity ratio of 39.9% substantially trails the industry median of 63.8% (IQR: 49.5%-74.7%), indicating higher financial risk and debt reliance. Current ratio of 116.1% falls well below the industry median of 284% (IQR: 210%-381%), signaling materially weaker liquidity positioning relative to peers.
Efficiency metrics reveal working capital management challenges. Asset turnover of 0.47x underperforms the industry median of 0.58x (IQR: 0.42-0.66), confirming lower asset productivity. Receivables turnover days of approximately 107 days exceed the industry median of 83 days (IQR: 68-115 days), while inventory turnover days exceeding 130 days significantly surpass the industry median of 109 days (IQR: 50-155 days), indicating slower working capital velocity. Operating working capital cycle substantially exceeds the industry median of 108 days (IQR: 72-143 days).
ROIC of 3.2% trails the industry median of 5.0% (IQR: 3.0%-10.0%), confirming capital efficiency disadvantage. Revenue growth of 4.6% YoY exceeds the industry median of 2.7% (IQR: -1.9%-7.9%), representing relative strength on the top line despite profitability challenges.
(※ Industry: Manufacturing (98 companies), Comparison: FY2025-Q3, Source: Proprietary analysis)
Structural profitability challenges require operational turnaround despite revenue growth momentum. The company achieved 4.6% revenue growth but experienced 32.5% operating income decline, indicating unit economics deterioration that demands management intervention. Operating margin compression of 3.8 percentage points from approximately 10.6% to 6.8% reflects either pricing erosion, product mix deterioration, or unabsorbed cost inflation. The PhotosensitivityMaterials segment's near-zero operating margin (0.2%) despite representing 61% of segment revenue signals a strategic challenge requiring either restructuring or repositioning. Recovery pathway depends on demonstrating margin stabilization and operational leverage restoration in coming quarters.
Working capital intensity and liquidity constraints represent material financial stress requiring immediate attention. The company's working capital cycle substantially exceeds industry norms, with receivables days of 107 days and inventory days exceeding 130 days tying up significant cash. Short-term borrowings increased 37% YoY to 63.0B yen while cash declined to 30.0B yen, resulting in cash coverage of only 0.48x. This deteriorating liquidity profile combined with elevated interest expenses (up 61% YoY) indicates refinancing risk and financial flexibility constraints. Management's ability to reduce working capital, extend debt maturities, or improve operating cash generation will be critical indicators of financial stability.
Dividend sustainability depends on cash generation recovery despite conservative payout ratio. The 27% payout ratio provides mathematical sustainability cushion, but the absence of operating cash flow disclosure and deteriorating working capital metrics raise questions about cash-backed dividend coverage. The company maintained dividends despite 35% earnings decline, signaling commitment to shareholder returns. However, continued dividend support requires operational improvements to restore profitability and cash conversion efficiency. Investors should monitor working capital trends, operating cash flow generation once disclosed, and management's strategic response to margin pressure as key indicators of long-term value creation capability and dividend sustainability.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.